Bevacizumab/triamcinoloneEndophthalmitis: 14 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1960卷 / 1期

关键词：

D O I：

10.1007/s40278-023-40933-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：105 / 105

相关论文

共 50 条

[21] Bevacizumab/dexamethasoneVarious toxicities: 6 case reports
Reactions Weekly, 2020, 1785 (1) : 112 - 112
[22] TriamcinoloneEndophthalmitis following intravitreal administration: case report
Reactions Weekly, 2011, 1347 (1) : 38 - 38
[23] TriamcinoloneEndophthalmitis following intravitreal administration: case report
Reactions Weekly, 2010, 1322 (1) : 30 - 30
[24] Bevacizumab/cyclophosphamideVarious toxicities: 5 case reports
Reactions Weekly, 2023, 1950 (1) : 92 - 92
[25] Bevacizumab/TemozolomideLack of efficacy: 2 case reports
Reactions Weekly, 2024, 2030 (1) : 98 - 98
[26] Aflibercept/bevacizumab/ranibizumabEndophthalmitis: 15 case reports
Reactions Weekly, 2023, 1950 (1) : 21 - 21
[27] Bevacizumab/oxaliplatinVarious toxicities: 10 case reports
Reactions Weekly, 2011, 1365 (1) : 10 - 10
[28] Aflibercept/bevacizumab/ranibizumabCataract: 6 case reports
Reactions Weekly, 2022, 1887 (1) : 30 - 30
[29] Bevacizumab/pazopanibVarious toxicities: 4 case reports
Reactions Weekly, 2019, 1758 (1) : 79 - 79
[30] Aflibercept/bevacizumab/ranibizumabEndophthalmitis: 7 case reports
Reactions Weekly, 2022, 1907 (1) : 28 - 28

← 1 2 3 4 5 →